Saltar al contenido
Merck
  • Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication.

Post-exposure administration of diazepam combined with soluble epoxide hydrolase inhibition stops seizures and modulates neuroinflammation in a murine model of acute TETS intoxication.

Toxicology and applied pharmacology (2014-12-03)
Stephen T Vito, Adam T Austin, Christopher N Banks, Bora Inceoglu, Donald A Bruun, Dorota Zolkowska, Daniel J Tancredi, Michael A Rogawski, Bruce D Hammock, Pamela J Lein
RESUMEN

Tetramethylenedisulfotetramine (TETS) is a potent convulsant poison for which there is currently no approved antidote. The convulsant action of TETS is thought to be mediated by inhibition of type A gamma-aminobutyric acid receptor (GABAAR) function. We, therefore, investigated the effects of post-exposure administration of diazepam, a GABAAR positive allosteric modulator, on seizure activity, death and neuroinflammation in adult male Swiss mice injected with a lethal dose of TETS (0.15mg/kg, ip). Administration of a high dose of diazepam (5mg/kg, ip) immediately following the second clonic seizure (approximately 20min post-TETS injection) effectively prevented progression to tonic seizures and death. However, this treatment did not prevent persistent reactive astrogliosis and microglial activation, as determined by GFAP and Iba-1 immunoreactivity and microglial cell morphology. Inhibition of soluble epoxide hydrolase (sEH) has been shown to exert potent anti-inflammatory effects and to increase survival in mice intoxicated with other GABAAR antagonists. The sEH inhibitor TUPS (1mg/kg, ip) administered immediately after the second clonic seizure did not protect TETS-intoxicated animals from tonic seizures or death. Combined administration of diazepam (5mg/kg, ip) and TUPS (1mg/kg, ip, starting 1h after diazepam and repeated every 24h) prevented TETS-induced lethality and influenced signs of neuroinflammation in some brain regions. Significantly decreased microglial activation and enhanced reactive astrogliosis were observed in the hippocampus, with no changes in the cortex. Combining an agent that targets specific anti-inflammatory mechanisms with a traditional antiseizure drug may enhance treatment outcome in TETS intoxication.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Acetona, ACS reagent, ≥99.5%
Sigma-Aldrich
Ácido clorhídrico, ACS reagent, 37%
Sigma-Aldrich
Ácido clorhídrico, ACS reagent, 37%
Sigma-Aldrich
Acetona, suitable for HPLC, ≥99.9%
Sigma-Aldrich
Acetona, HPLC Plus, for HPLC, GC, and residue analysis, ≥99.9%
Sigma-Aldrich
Cloruro de hidrógeno solution, 4.0 M in dioxane
Sigma-Aldrich
Ácido clorhídrico solution, 1.0 N, BioReagent, suitable for cell culture
Sigma-Aldrich
Hexano, suitable for HPLC, ≥95%
Sigma-Aldrich
Hexano, ReagentPlus®, ≥99%
Sigma-Aldrich
Hexano, Laboratory Reagent, ≥95%
Sigma-Aldrich
Ácido clorhídrico, 36.5-38.0%, BioReagent, for molecular biology
Sigma-Aldrich
Ácido clorhídrico, 37 wt. % in H2O, 99.999% trace metals basis
Sigma-Aldrich
Ácido clorhídrico, meets analytical specification of Ph. Eur., BP, NF, fuming, 36.5-38%
Sigma-Aldrich
Cloruro de hidrógeno solution, 2.0 M in diethyl ether
Sigma-Aldrich
Hexano, HPLC Plus, for HPLC, GC, and residue analysis, ≥95%
Supelco
Alcohol bencílico, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Alcohol bencílico, ReagentPlus®, ≥99%
Sigma-Aldrich
1,2-Propanediol, ≥99.5% (GC), FCC, FG
Sigma-Aldrich
1,2-Propanediol, ACS reagent, ≥99.5%
Sigma-Aldrich
Alcohol bencílico, ACS reagent, ≥99.0%
Supelco
Ácido clorhídrico solution, volumetric, 0.1 M HCl (0.1N), endotoxin free